Nyt tulee lisättyä taas vähän vastuutonta spekulaatiota lankaan, mutta tuli taas lueskeltua näitä JPM26:n ensimmäisen päivän päivityksiä. https://www.fiercepharma.com/pharma/fierce-pharmas-jpm26-tracker-day-1
“As for business development, Gilead has been involved in some of the behind-the-scenes discussions surrounding recent deals in the industry, CFO Andy Dickinson said during the Q&A portion of Gilead’s presentation. Those talks didn’t materialize for one reason or another, but Gilead continues to explore “small to medium” deals to bolster its current portfolio, the CFO said.”